Search Within

Richard M Steingart

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (16)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (34)
  2. Cardiology (34)
  3. Department of Medicine (34)
  4. Division of Subspecialty Medicine (34)
  5. Epidemiology and Biostatistics (34)
  6. Survivorship Research (32)

More Groups

People
  1. Chau Dang (25)
  2. Anthony Yu (16)
  3. Jennifer Liu (16)
  4. Chaya Moskowitz (14)
  5. Clifford Hudis (14)
  6. Sujata Patil (14)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2021 (1)
  4. 2020 (5)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Journal of the American College of Cardiology (6)
  3. Clinical Cancer Research (2)
  4. JAMA Cardiology (2)
  5. Journal of the American Heart Association (2)
  6. Advances in Radiation Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Elsevier Science, Inc. (6)
  3. American Association for Cancer Research (3)
  4. American Medical Association (3)
  5. Wiley Blackwell (3)
  6. Biomed Central Ltd (2)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety
    Meeting Abstract

    Dickler, M. N.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Sugarman, S.; Norton, L.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab plus dose-dense doxorubicin/cyclophosphamide followed by nanoparticle albumin-bound paclitaxel in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Rugo, H.; Paulson, M.; Rourke, M.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Park, J.; more...
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Cardiac toxicity of 5FU: Does prophylactic telemetry monitoring of patients at increased risk for cardiac toxicity improve safety? A 10-year experience
    Meeting Abstract

    Pizzolato, J.; Baum, M. S.; Steingart, R. M.; Gonen, M.; Minsky, B. D.; Saltz, L. B.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save